Moenhth impacting almost every aspect of health
About Moenhth
At Moenhth, we are more than just a pharmacy distributor; we're your trusted partner in healthcare. Founded on the principles of integrity and reliability, our mission is to deliver quality pharmaceutical products while prioritizing customer satisfaction above all else. With a relentless commitment to excellence, we strive to exceed industry standards and continuously improve our services to meet the evolving needs of our customers. At Moenhth, your health and well-being are our top priorities, driving us to uphold the highest standards of quality, transparency, and professionalism in everything we do.
Addressing Drug Shortages
We are dedicated to assisting in the resolution of the various problems causing medication shortages, and we have extensive experience in pharmaceutical distribution, supply chain analytics, and market access dynamics.
Delivering on Innovative Medical Breakthroughs
Discover how Moenhth Pharmaceutical Distribution facilitates the seamless supply of essential medications, ensuring widespread access and efficient delivery to healthcare providers and patients, thereby enhancing healthcare outcomes and advancing medical accessibility.
Supply Chain Global & Resilience
We provide global distribution solutions tailored to ensure seamless access to vital medications worldwide. From advanced supply chain strategies to meticulous logistics management, count on us for reliability and resilience.
Providing an Oasis to Pharmacy Deserts
Moenhth innovative approach aims to tackle pharmacy deserts in an underserved community.
Our Clients
Charlie Anderson
MedSolutions Pharmacy
Dr. David Patel
MedLife Clinics
Emily Smith
HealthWell Pharmacies
Sarah Johnson
CarePoint Pharmacy
Contact Moenhth
Reports
Recent
Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib
Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib OVERVIEW Clinical outcomes are excellent with use of radiofrequency (RF)...
Read MoreFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer OVERVIEW NEW YORK & COPENHAGEN, Denmark–(BUSINESS WIRE)– Pfizer...
Read MoreFDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea
FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea Introduction Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar...
Read MoreInfluenza (Flu) Antiviral Drugs and Related Information
Influenza (Flu) Antiviral Drugs and Related Information Introduction The term influenza refers to illness caused by influenza virus. This is...
Read MoreTamiflu FDA Review
Tamiflu FDA Review Review Tamiflu (oseltamivir phosphate) is an oral anti-viral drug approved for the treatment of acute, uncomplicated influenza...
Read MoreMetastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates
Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates OVERVIEW For patients with metastatic or advanced cancer, treatment...
Read MoreMortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season
Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season OVERVIEW In fall/winter 2023/2024, the risk for death in...
Read MoreStudy Identifies Factors That Predict Driving Cessation in Seniors
Study Identifies Factors That Predict Driving Cessation in Seniors OVERVIEW Among older adults, factors associated with future driving cessation include...
Read MoreRelenza Pharmocology
Relenza (Zanamivir) Pharmocology Introduction Zanamivir is the pharmaceutically active component of the antiviral medication Relenza. This drug stops the replication...
Read MoreGLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults
GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults OVERVIEW For adolescents and young adults, glucagon-like...
Read MoreRelenza FDA Review
Relenza (zanamivir) FDA Review Introduction Relenza (zanamivir) is an inhalation powder for oral inhalation approved for treatment of acute uncomplicated...
Read MoreVolume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium
Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium OVERVIEW Ongoing leisure-time physical activity, even at high volumes,...
Read MoreGlobal Life Expectancy, Disease Burden Set to Keep Improving
Global Life Expectancy, Disease Burden Set to Keep Improving OVERVIEW Life expectancy and age-standardized disease burden are expected to continue...
Read MoreFDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus
Influenza (Flu) Antiviral Drugs and Related Information OVERVIEW The U.S. Food and Drug Administration has approved a 200-mg subcutaneous route...
Read MoreFDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea
FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea OVERVIEW Food and Drug Administration (FDA) has approved Opuviz (aflibercept-yszy), an interchangeable biosimilar...
Read MoreUltraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children
Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children OVERVIEW High ultraprocessed food (UPF) consumption in young children is associated with...
Read MoreHospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject™ Units and Labetalol Hydrochloride Injection, USP Carpuject™ Units Due To The Potential For Incomplete Crimp Seals
Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject,Due To The Potential For Incomplete Crimp Seals OVERVIEW...
Read More